JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4651
Nicolet Bankshares
NIC
$3.45B
| $114K | ﹤0.01% |
1,911
-213
| -10% | -$11.8K |
2017 Q4
5 quarters
|
|
4652
NVE Corp
NVEC
$552M
| $114K | ﹤0.01% |
1,164
-54
| -4% | -$5.21K |
2017 Q4
5 quarters
|
|
4653
Corbus Pharmaceuticals
CRBP
$113M
| $113K | ﹤0.01% |
542
+117
| +28% | +$25.8K |
2017 Q4
5 quarters
|
|
4654
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$370M
| $113K | ﹤0.01% |
4,242
| – | – |
2017 Q3
6 quarters
|
|
4655
Legacy Housing
LEGH
$694M
| $112K | ﹤0.01% |
+9,441
| New | +$126K |
2019 Q1
0 quarters
|
|
|
LDL
4656
DELISTED
Lydall, Inc.
LDL
| $112K | ﹤0.01% |
4,728
-108,363
| -96% | -$2.74M |
2013 Q2
23 quarters
|
|
4657
Fidelity Dividend ETF for Rising Rates
FDRR
$756M
| $111K | ﹤0.01% |
3,500
+500
| +17% | +$15.4K |
2018 Q4
1 quarter
|
|
4658
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$121M
| $111K | ﹤0.01% |
2,943
-267
| -8% | -$10.1K |
2017 Q2
7 quarters
|
|
|
CHMA
4659
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $111K | ﹤0.01% |
21,333
+7,275
| +52% | +$32.1K |
2018 Q4
1 quarter
|
|
4660
Inovio Pharmaceuticals
INO
$119M
| $110K | ﹤0.01% |
2,451
+73
| +3% | +$3.68K |
2014 Q3
18 quarters
|
|
4661
Teucrium Corn Fund
CORN
$129M
| $109K | ﹤0.01% |
7,142
+50
| +0.7% | +$801 |
2016 Q2
11 quarters
|
|
|
ORC
4662
Orchid Island Capital
ORC
$997M
| $109K | ﹤0.01% |
3,330
+656
| +25% | +$22.4K |
2017 Q4
5 quarters
|
|
4663
QCR Holdings
QCRH
$1.64B
| $109K | ﹤0.01% |
3,233
-149
| -4% | -$5.12K |
2016 Q4
9 quarters
|
|
|
CTRL
4664
DELISTED
Control4 Corporation
CTRL
| $109K | ﹤0.01% |
6,445
-71,121
| -92% | -$1.28M |
2017 Q3
6 quarters
|
|
4665
CALL
Hilton Grand Vacations
HGV
$2.65B
| $108K | ﹤0.01% |
3,500
| – | – |
2018 Q4
1 quarter
|
|
|
CVLY
4666
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $108K | ﹤0.01% |
5,346
+11
| +0.2% | +$235 |
2017 Q4
5 quarters
|
|
|
ATRS
4667
DELISTED
Antares Pharma, Inc.
ATRS
| $107K | ﹤0.01% |
35,221
-1,656
| -4% | -$5.37K |
2017 Q4
5 quarters
|
|
|
ACBI
4668
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $107K | ﹤0.01% |
6,021
-498
| -8% | -$9.19K |
2017 Q4
5 quarters
|
|
|
CTLP
4669
DELISTED
Cantaloupe
CTLP
| $106K | ﹤0.01% |
25,464
-1,593
| -6% | -$7.14K |
2017 Q4
5 quarters
|
|
4670
WisdomTree International Equity Fund
DWM
$655M
| $106K | ﹤0.01% |
2,102
+41
| +2% | +$2.04K |
2015 Q4
13 quarters
|
|
|
SEE
4671
PUT
DELISTED
Sealed Air
SEE
| $106K | ﹤0.01% |
2,300
+2,200
| +2,200% | +$91.3K |
2018 Q3
2 quarters
|
|
4672
Metallus
MTUS
$872M
| $106K | ﹤0.01% |
9,759
-15,930
| -62% | -$184K |
2017 Q4
5 quarters
|
|
|
BREW
4673
DELISTED
Craft Brew Alliance, Inc.
BREW
| $106K | ﹤0.01% |
7,626
+4,373
| +134% | +$69.3K |
2017 Q3
6 quarters
|
|
4674
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.2B
| $105K | ﹤0.01% |
2,636
-32,237
| -92% | -$1.26M |
2018 Q3
2 quarters
|
|
4675
LSI Industries
LYTS
$777M
| $105K | ﹤0.01% |
39,805
-95,370
| -71% | -$307K |
2013 Q2
23 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.